Jack Higgins
Chief Tech/Sci/R&D Officer at IMMUNOME, INC.
Net worth: - $ as of 30/05/2024
Network origin in Jack Higgins first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX.
7
| Extinct | Biotechnology | 7 |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.
3
| Subsidiary | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jack Higgins via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| MOLECULAR TEMPLATES, INC. | Biotechnology | President Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Hydrobuilder Holdings LLC
 Hydrobuilder Holdings LLC Internet Software/ServicesTechnology Services Hydrobuilder Holdings LLC is a leading omnichannel platform in the hydroponics, CEA, and specialty agriculture industry. The private company is based in the United States, with a retail footprint in four states and commercial warehouse direct capabilities in 17 states. The American company serves a wide range of customers, from hobbyists to large commercial growers, through its online, retail, and warehouse direct channels. These companies include Greencoast, Hydrobuilder.com, Elevated Equipment and Supply, and Way to Grow. Hydrobuilder Holdings was founded in October 2020 and has acquired four market-leading companies across different sales channels and geographies. The CEO of Hydrobuilder Holdings is Markus Alan Hockenson. | Internet Software/Services | Director/Board Member Director/Board Member Director/Board Member | |
| COMMITTED CAPITAL ACQUISITION CORPORATION II | Financial Conglomerates | Chief Executive Officer Founder | |
Plastron Acquisition Corp. IV
 Plastron Acquisition Corp. IV Financial ConglomeratesFinance Plastron Acquisition Corp. IV operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on June 22, 2011 and is headquartered in New York, NY. | Financial Conglomerates | President Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Rocket Global Acquisition Corp.
 Rocket Global Acquisition Corp. Financial ConglomeratesFinance Rocket Global Acquisition Corp. operates as a blank check company. The firm was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated on February 9, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| THE ONE GROUP HOSPITALITY, INC. | Restaurants | Chairman Director/Board Member | |
Committed Capital Acquisition Corp. III
 Committed Capital Acquisition Corp. III MiscellaneousMiscellaneous Committed Capital Acquisition Corp. III operates as a development stage company. The firm was organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, exchangeable stock transaction or other similar business transaction. The company was founded by Michael Rapoport and Philip R. Wagenheim on May 18, 2011 and is headquartered in New York, NY. | Miscellaneous | Chief Executive Officer Founder | |
Just Another Acquisition Corp.
 Just Another Acquisition Corp. Financial ConglomeratesFinance Just Another Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Plastron Acquisition Corp. III
 Plastron Acquisition Corp. III Financial ConglomeratesFinance Plastron Acquisition Corp. III operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on May 24, 2011 and is headquartered in New York, NY. | Financial Conglomerates | President Director/Board Member | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
Brand & Services Acquisition Corp.
 Brand & Services Acquisition Corp. MiscellaneousMiscellaneous Brand & Services Acquisition Corp. operates as a blank check company. The company does not have any specific business combination under consideration or contemplation. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on February 14, 2007 and is headquartered in Ft. Lauderdale, FL. | Miscellaneous | Chairman Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree | |
Oscar Gruss & Son, Inc.
 Oscar Gruss & Son, Inc. Investment Banks/BrokersFinance Founded in 1947 by Oscar Gruss and Emanuel Gruss, Oscar Gruss & Son, Inc. is a full-service broker/dealer located in New York City. The firm offers focused independent research and trading and execution services focusing particularly on special situations and convertibles. They conduct business with major Israeli institutional clients who execute trades in U.S. equities and options. Oscar Gruss & Son also maintains a trading desk in New York solely dedicated to European investors. The firm is a member of the NYSE and the SIPC. | Investment Banks/Brokers | Founder Founder | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Boston College | College/University | Undergraduate Degree Director/Board Member | |
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| ZYNERBA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO President | |
SVB Securities Holdings LLC
 SVB Securities Holdings LLC Financial ConglomeratesFinance SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA. | Financial Conglomerates | President | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | President | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Biotechnology | Director/Board Member | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Great Oaks Venture Capital BZ LLC
 Great Oaks Venture Capital BZ LLC Investment ManagersFinance Great Oaks Venture Capital BZ LLC (Great Oaks Venture Capital) is a venture capital firm founded in 2005 by Andrew K. Boszhardt Jr. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Undergraduate Degree | |
Cyanco International LLC
 Cyanco International LLC Chemicals: SpecialtyProcess Industries Cyanco International LLC engages in mining solid sodium cyanide. The company is headquartered in Pearland, TX. | Chemicals: Specialty | Chief Executive Officer | |
Signa Chemistry
 Signa Chemistry Metal FabricationProducer Manufacturing Signa Chemistry develops stabilized reactive metals. | Metal Fabrication | Founder | |
Cyanco Corp.
 Cyanco Corp. Industrial SpecialtiesProcess Industries Cyanco Corp. supplies commercial mining explosives. It offers liquid and solid sodium cyanide. The firm offers its products to gold mines. The company was founded in 1988 and is headquartered in Reno, NV. | Industrial Specialties | President | |
Cyanco Holding Corp.
 Cyanco Holding Corp. Chemicals: SpecialtyProcess Industries Cyanco Holding Corp. supplies products to the mining industries. The company was founded in 2008 and is headquartered in Reno, NV. | Chemicals: Specialty | Chief Executive Officer | |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Enavate Sciences is a platform created by Patient Square Capital that supports therapeutic companies advancing medicines and enabling technologies to address patient needs. Enavate Sciences is based in New York, NY. The company provides capital support and operational experience to a diverse portfolio of therapeutics companies, aiming to accelerate innovation. James P. Boylan has been the CEO of the company since 2022. | Financial Conglomerates | Chief Executive Officer | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Lehigh University | College/University | Undergraduate Degree | |
| MediVector, Inc. | Corporate Officer/Principal | ||
| Wesleyan University | College/University | Undergraduate Degree | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Corporate Officer/Principal | |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Financial Conglomerates | Chief Operating Officer | |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 50 |
| China | 2 |
Sectoral
| Finance | 17 |
| Health Technology | 15 |
| Consumer Services | 11 |
| Process Industries | 4 |
| Producer Manufacturing | 3 |
Operational
| Director/Board Member | 117 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 35 |
| President | 30 |
| Chief Executive Officer | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Steve Gullans | 26 |
| Jean-Jacques Bienaimé | 22 |
| Philip Wagenheim | 21 |
| Rapp Rapoport | 20 |
| John LaMattina | 20 |
| Clay Siegall | 18 |
| Isaac Barchas | 14 |
| Carol Schafer | 13 |
| Richard Baron | 13 |
| Michael Lefenfeld | 12 |
| Dennis Giesing | 11 |
| Purnanand Sarma | 10 |
| James Boylan | 10 |
| Bruce Turner | 9 |
| Jason Kim | 9 |
- Stock Market
- Insiders
- Jack Higgins
- Company connections
